Full Text View
Tabular View
No Study Results Posted
Related Studies
A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test
This study has been completed.
First Received: May 16, 2008   Last Updated: April 14, 2009   History of Changes
Sponsored by: University of Pittsburgh
Information provided by: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00682851
  Purpose

This research is being done to see if two rapid bedside tests (OSOM Trichomonas Rapid Test and BVBlue Test) that give results in 10 minutes are as accurate as standard tests (that take up to 7 days to get results) to diagnose common vaginal infections (Trichomonas and bacterial vaginosis).

Both rapid tests (OSOM and BVBlue) are approved by the Food and Drug Administration (FDA) to be used by healthcare professionals to aid in the diagnosis of these infections. This study is being done to validate (or confirm)the accuracy of these tests. THis study may help researchers decide if these tests could be used in remote research settings (in place of the standard office testing) to increase diagnosis and prompt treatment of these vaginal infections.


Condition Intervention
Bacterial Vaginosis
Trichomonas Vaginalis
Device: OSOM Trichomonas Rapid Test
Device: OSOM BVBlue Test

Study Type: Interventional
Study Design: Diagnostic, Open Label, Active Control, Single Group Assignment
Official Title: A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test

Further study details as provided by University of Pittsburgh:

Primary Outcome Measures:
  • To compare the sensitivity and specificity of the OSOM Test to wet mount microscopy, Trichomonas culture, and PCR in diagnosing Trichomonas vaginalis [ Time Frame: Visit 1 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • To compare the sensitivity and specificity of the BVBlue Test to Amsel criteria and Gram Stain (Nuget scoring) in diagnosing BV. [ Time Frame: Visit 1 ] [ Designated as safety issue: No ]

Estimated Enrollment: 500
Study Start Date: July 2008
Study Completion Date: April 2009
Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: OSOM Trichomonas Rapid Test
    Rapid test run using vaginal discharge collected via a cotton swab
    Device: OSOM BVBlue Test
    rapid test run using vaginal discharge collected using a cotton swab
  Eligibility

Ages Eligible for Study:   15 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • At least 15 years of age at time of enrollment
  • Ability to provide written informed consent

Exclusion Criteria:

  • Currently menstruating or bleeding
  • Use of an antibiotic to treat BV or Trichomonas within the past 7 days
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00682851

Locations
United States, Pennsylvania
Magee-Womens Hospital of UPMC
Pittsburgh, Pennsylvania, United States, 15213
Sponsors and Collaborators
University of Pittsburgh
Investigators
Principal Investigator: Sharon L Hillier, PhD University of Pittsburgh
  More Information

No publications provided

Responsible Party: University of PIttsburgh ( Sharon L. Hillier, PhD )
Study ID Numbers: PRO08020012
Study First Received: May 16, 2008
Last Updated: April 14, 2009
ClinicalTrials.gov Identifier: NCT00682851     History of Changes
Health Authority: United States: Institutional Review Board

Study placed in the following topic categories:
Genital Diseases, Female
Bacterial Infections
Vaginosis, Bacterial
Vaginitis
Vaginal Diseases

Additional relevant MeSH terms:
Genital Diseases, Female
Bacterial Infections
Vaginosis, Bacterial
Vaginitis
Vaginal Diseases

ClinicalTrials.gov processed this record on July 06, 2009